HemaSphere Journal

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

HemaSphere Journal

Jan 15, 2025, 14:01 | Science

Kai Rejeski: Delineating the prognostic significance of immune reconstitution in CAR-T recipients

Kai Rejeski, Research Fellow at Memorial Sloan Kettering Cancer Center, shared an article by Sophia…

Nov 17, 2024, 15:39 | Insight

Myeloma Paper of the Day, November 17th, suggested by Robert Orlowski

Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Spanish study of IgM MGUS…

Jul 7, 2024, 09:44 | Insight

Myeloma Paper of the Day, July 7th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Comparison of International Myeloma Working…

Jul 4, 2024, 08:53 | Blog

Jan Cools: 2023 journal impact factor of HemaSphere Journal is 12.1

Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), made…

Mar 9, 2024, 14:13 | Insight

Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples

Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), shared…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023